Diagnostyka SA (DIAP)

Currency in PLN
148.50
+0.50(+0.34%)
Delayed Data·
Unusual trading volume
Trading near 52-week Low
DIAP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
146.40152.00
52 wk Range
146.40219.90
Key Statistics
Bid/Ask
148.30 / 148.50
Prev. Close
148
Open
148.8
Day's Range
146.4-152
52 wk Range
146.4-219.9
Volume
180.27K
Average Volume (3m)
47.99K
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DIAP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
211.28
Upside
+42.28%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Diagnostyka SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Diagnostyka S.A. operates as a medical laboratory. The company was founded in 1998 and is headquartered in Kraków, Poland.

Employees
7836
Market
Poland

Compare DIAP to Peers and Sector

Metrics to compare
DIAP
Peers
Sector
Relationship
P/E Ratio
18.7x18.6x−0.4x
PEG Ratio
1.580.320.00
Price/Book
10.1x3.0x2.6x
Price / LTM Sales
2.2x2.0x3.2x
Upside (Analyst Target)
44.0%27.5%46.7%
Fair Value Upside
Unlock18.6%7.6%Unlock

Analyst Ratings

4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 211.28
(+42.28% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jefferies
Hold204.00+37.28%190.00DowngradeSep 29, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.91%
Dividend Yield
2.14%
Industry Median 2.51%
Annualised payout
3.31
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 20, 2026
EPS / Forecast
-- / --
Revenue / Forecast
620.9M / --
EPS Revisions
Last 90 days

DIAP Income Statement

People Also Watch

106.14
XTB
-0.66%
128.18
PKN
-0.28%
288.80
SNTP
+0.21%
96.11
PKO
-0.62%

FAQ

What Is the Diagnostyka (DIAP) Stock Price Today?

The Diagnostyka stock price today is 148.50 PLN.

What Stock Exchange Does Diagnostyka Trade On?

Diagnostyka is listed and trades on the Warsaw Stock Exchange.

What Is the Stock Symbol for Diagnostyka?

The stock symbol for Diagnostyka is "DIAP."

What Is the Diagnostyka Market Cap?

As of today, Diagnostyka market cap is 5.00B PLN.

What Is Diagnostyka's Earnings Per Share (TTM)?

The Diagnostyka EPS (TTM) is 7.91.

When Is the Next Diagnostyka Earnings Date?

Diagnostyka will release its next earnings report on May 28, 2026.

From a Technical Analysis Perspective, Is DIAP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Diagnostyka Stock Split?

Diagnostyka has split 0 times.

How Many Employees Does Diagnostyka Have?

Diagnostyka has 7836 employees.

What is the current trading status of Diagnostyka (DIAP)?

As of Apr 24, 2026, Diagnostyka (DIAP) is trading at a price of 148.50 PLN, with a previous close of 148.00 PLN. The stock has fluctuated within a day range of 146.40 PLN to 152.00 PLN, while its 52-week range spans from 146.40 PLN to 219.90 PLN.

What Is Diagnostyka (DIAP) Price Target According to Analysts?

The average 12-month price target for Diagnostyka is 211.28 PLN, with a high estimate of 230 PLN and a low estimate of 188 PLN. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +42.28% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.